Researchers at Cold Spring Harbor Laboratory have found that blocking a protein called PTP1B can restore memory and reduce harmful plaque buildup in mice with Alzheimer's disease. PTP1B interferes with brain immune cells called microglia, which normally clear toxic amyloid-beta deposits. When PTP1B is inhibited, these immune cells become more effective at cleaning up the brain. What makes this finding especially interesting is that PTP1B is already a known target for metabolic conditions like obesity and type 2 diabetes — both recognized risk factors for Alzheimer's. This dual relevance suggests a single treatment strategy could address multiple disease pathways simultaneously, potentially offering broader protection than current therapies that focus narrowly on plaque reduction.
